Catalio Capital Management
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio5 active
0Portfolio exitsAcquired or listed
2Raises, 12 monthsLatest: Iambic Therapeutics
15Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Iambic Therapeutics | Biotech | Active | Sep 9, 2026 | $323.1M |
| Imbria Pharmaceuticals | Biotech | Active | Dec 16, 2025 | $140.2M |
| Alentis Therapeutics | Biotech | Active | — | — |
| Lassen Therapeutics | Biotech | Active | — | — |
| Parabilis Medicines | Biotech | Active | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#234
Raises, 12 months#12
Co-investors#133
Co-investors
- RA CapitalVenture capital3 shared
- Longitude CapitalVenture capital2 shared
- AbingworthVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
- Deep Track CapitalVenture capital1 shared
- Farallon Capital ManagementPrivate equity1 shared
- Foresite CapitalVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
- Goldman Sachs AlternativesVenture capital1 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.